Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
Free Radical Biology & Medicine|March 10, 2017
Microvascular NADPH oxidase in health and diseaseYao Li, Patrick J PaganoExperimental Biology and Medicine (Maywood, N.J.)|March 4, 2006
Hydrogen peroxide as a paracrine vascular mediator: regulation and signaling leading to dysfunctionNoelia Ardanaz, Patrick J PaganoInternational Journal of Hypertension|April 23, 2013
Strategies Aimed at Nox4 Oxidase Inhibition Employing Peptides from Nox4 B-Loop and C-Terminus and p22 (phox) N-Terminus: An Elusive TargetGábor Csányi, Patrick J PaganoMethods in Molecular Biology (Clifton, N.J.)|June 8, 2019
Rational Design and Delivery of NOX-Inhibitory PeptidesEugenia Cifuentes-Pagano, Patrick J PaganoArteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2002
The reactive adventitia: fibroblast oxidase in vascular functionFederico E Rey, Patrick J PaganoHypertension (Dallas, Tex. : 1979)|January 4, 2021
The Enigmatic Vascular NOX: From Artifact to Double Agent of Change: Arthur C. Corcoran Memorial Lecture - 2019Patrick J Pagano, Eugenia Cifuentes-PaganoCardiovascular Research|August 11, 2007
Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?Mounir J Haurani, Patrick J PaganoCurrent Opinion in Nephrology and Hypertension|February 17, 2006
Targeting reactive oxygen species in hypertensionM Eugenia Cifuentes, Patrick J PaganoCellular and Molecular Life Sciences : CMLS|May 16, 2012
NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTSEugenia Cifuentes-Pagano, Gabor Csanyi, Patrick J PaganoClinical Science (London, England : 1979)|January 28, 2016
NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?Sanghamitra Sahoo, Daniel N Meijles, Patrick J PaganoPageof 9